CIK 0001752828
- Emerging growth company
Celularity Inc
Sign in to watch- Ticker
- CELU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831702591
- Phone
- +1 908-768-2170
- Business address
- 170 PARK AVE, FLORHAM PARK, NJ, 07932
- Former names
- GX Acquisition Corp.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Medical Officer gave up 52,762 shares (to pay taxes)
- 4 Shares withheld for taxes Haines John R gave up 70,350 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 43,968 shares (to pay taxes)
- 4 Shares withheld for taxes Pres, Functional Regeneration gave up 32,720 shares (to pay taxes)
- 4 Shares withheld for taxes Fletcher Kyle gave up 39,571 shares (to pay taxes)
- 4 Open-market buy 10% owner bought 21,410,983 shares at $0.25 ($5,331,335)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 18,422,124 shares at an average $0.16 ($2,984,294)
- 4 Open-market sale 10% owner sold 15,371,697 shares
- 4 Grant or award Chief Medical Officer acquired 875,000 shares (grant or award)
- 4/A Shares withheld for taxes Director gave up 10,844 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 199,921 shares (grant or award)
- 4 Grant or award Director acquired 199,921 shares (grant or award)
- 4 Grant or award Director acquired 199,921 shares (grant or award)
- 4 Grant or award Director acquired 199,921 shares (grant or award)
- 4 Grant or award Director acquired 199,921 shares (grant or award)
Page 4 of 10 · 191 filings